Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiguo Hu

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Blood|June 13, 2012
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myelomaYu-Tzu Tai, Betty Y Chang, Sun-Young Kong, et al.
Blood|April 28, 2012
Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myelomaNaoya Mimura, Mariateresa Fulciniti, Gullu Gorgun, et al.
Science Advances|July 29, 2021
Characterizing dedifferentiation of thyroid cancer by integrated analysisHan Luo, Xuyang Xia, Gyeong Dae Kim, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 29, 2024
Dynamics of The Γδtcr Repertoires During The Dedifferentiation Process and Pilot Implications for Immunotherapy of Thyroid CancerQing Hao, Ruicen Li, Hancong Li, et al.
Nature Communications|November 5, 2022
Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironmentHan Luo, Xuyang Xia, Li-Bin Huang, et al.
Nature Genetics|July 13, 2021
Genome-scale screens identify factors regulating tumor cell responses to natural killer cellsMichal Sheffer, Emily Lowry, Nicky Beelen, et al.
Cell Reports|January 6, 2021
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of OncoproteinsRyosuke Shirasaki, Geoffrey M Matthews, Sara Gandolfi, et al.
Science (New York, N.Y.)|February 19, 2021
SARS-CoV-2 M<sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse modelJingxin Qiao, Yue-Shan Li, Rui Zeng, et al.
Nature Cancer|May 26, 2023
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasiasRicardo de Matos Simoes, Ryosuke Shirasaki, Sondra L Downey-Kopyscinski, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Blood|June 13, 2012
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myelomaYu-Tzu Tai, Betty Y Chang, Sun-Young Kong, et al.
Blood|April 28, 2012
Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myelomaNaoya Mimura, Mariateresa Fulciniti, Gullu Gorgun, et al.
Science Advances|July 29, 2021
Characterizing dedifferentiation of thyroid cancer by integrated analysisHan Luo, Xuyang Xia, Gyeong Dae Kim, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 29, 2024
Dynamics of The Γδtcr Repertoires During The Dedifferentiation Process and Pilot Implications for Immunotherapy of Thyroid CancerQing Hao, Ruicen Li, Hancong Li, et al.
Nature Communications|November 5, 2022
Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironmentHan Luo, Xuyang Xia, Li-Bin Huang, et al.
Nature Genetics|July 13, 2021
Genome-scale screens identify factors regulating tumor cell responses to natural killer cellsMichal Sheffer, Emily Lowry, Nicky Beelen, et al.
Cell Reports|January 6, 2021
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of OncoproteinsRyosuke Shirasaki, Geoffrey M Matthews, Sara Gandolfi, et al.
Science (New York, N.Y.)|February 19, 2021
SARS-CoV-2 M<sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse modelJingxin Qiao, Yue-Shan Li, Rui Zeng, et al.
Nature Cancer|May 26, 2023
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasiasRicardo de Matos Simoes, Ryosuke Shirasaki, Sondra L Downey-Kopyscinski, et al.
Pageof 6